More Immutep Ltd news Immutep LtdASX: IMM Ulcerative Colitis Phase II Study of GSK2831781 Discontinued Jan 22, 2021 at 3:15 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
